VALTREX - 0173-0565-04 - (valacyclovir hydrochloride)

Alphabetical Index


Drug Information of VALTREX

Product NDC: 0173-0565
Proprietary Name: VALTREX
Non Proprietary Name: valacyclovir hydrochloride
Active Ingredient(s): 1    g/1 & nbsp;   valacyclovir hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of VALTREX

Product NDC: 0173-0565
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020487
Marketing Category: NDA
Start Marketing Date: 20020812

Package Information of VALTREX

Package NDC: 0173-0565-04
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0173-0565-04)

NDC Information of VALTREX

NDC Code 0173-0565-04
Proprietary Name VALTREX
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (0173-0565-04)
Product NDC 0173-0565
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name valacyclovir hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20020812
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name VALACYCLOVIR HYDROCHLORIDE
Strength Number 1
Strength Unit g/1
Pharmaceutical Classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient]

Complete Information of VALTREX


General Information